Ricerca avanzata

Attualmente, Katharine Knobil occupa la posizione di Chief Medical Officer di Agilent Technologies, Inc. La dottoressa Knobil è anche nel consiglio di amministrazione di Arena Pharmaceuticals, Inc. e membro delle Accademie Nazionali delle Scienze. Il dottor Knobil ha precedentemente occupato la posizione di Chief Medical Officer, Head-Research & Development presso Kaleido Biosciences, Inc. e Chief Medical Officer & Senior Vice President presso GlaxoSmithKline LLC. Il Dr. Knobil ha conseguito una laurea presso la Cornell University e un dottorato presso la University of Texas Southwestern Medical Center.

Ms. Katharine J.
O'Donovan is a Portfolio Manager at FMR Investment Management (UK) Ltd.
She joined the firm in May 2008 as a Research Analyst for the European bank sector.
Prior to joining FMR, Ms. O’Donovan spent 10 years each on the buy side and sell side evaluating at European banks, and subsequently global financials.
She was at First State Investments from 2007 through 2008 researching financials on the global team.
From 1999 to 2007, Ms. O’Donovan covered European banks including the UK at Credit Suisse Asset Management.
From 1989 to 1999, she was a sell side analyst of European banks, at what is now Deutsche Bank.

Katharine Jane Collyer currently works at Sydney & London Properties Ltd., as Secretary & Director and Gross-Hill Properties Ltd., as Secretary & Director.

Katharine R.
Henderson is currently the President, Chief Executive Officer & Director at Interfaith Alliance of Central California and also serves as a Director at The New York Women's Foundation.
Previously, she served as the Ex-Officio Director at Auburn Theological Seminary from 2020 to 2021.